selective serotonin reuptake inhibitor

(redirected from Serotonin reuptake inhibitors)
Also found in: Medical.
Related to Serotonin reuptake inhibitors: Effexor, SSRI

selective serotonin reuptake inhibitor

n.
An SSRI.
References in periodicals archive ?
Additionally, the analysis identified two factors, usage of selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors for management of depression and usage of Aprepitant for nausea management, which were correlated to removal rates and that will help lead to further improvements of post-placement symptom management.
Selective serotonin reuptake inhibitors (SSRIs) are likely associated with a moderate increased risk of upper gastrointestinal (UGI) bleeding.
Among them, citalopram, fluoxetine, and paroxetine belong to selective serotonin reuptake inhibitors (SSRIs), first-line therapeutic agents for treating a wide range of psychiatric disorders such as major depression, generalized anxiety disorder and post-traumatic disorder, to name but a few.
Selective serotonin reuptake inhibitors (SSRIs) are the mainstay of pharmacological treatment for both depression and anxiety disorders.
NORWAY -- Administering proton pump inhibitors (PPIs), which are used to relieve gastroesophageal reflux, together with selective serotonin reuptake inhibitors (SSRIs), which are used to treat depression, has been observed to elevate blood levels of SSRIs by significant amounts.
All had failed to respond adequately to treatment with selective serotonin reuptake inhibitors (SSRIs) or selective serotonin-norepinephrine reuptake inhibitors (SNRIs), according to Dr.
Sexual side effects are most often associated with serotonin and norepinephrine reuptake inhibitors (SNRIs), selective serotonin reuptake inhibitors (SSR1s), monoamine oxidase inhibitors (MAOIs) and tricyclic and tetracyclic antidepressants.
Serotonin is the target of the popular antidepressants known as selective serotonin reuptake inhibitors (SSRIs), which prolong the effect of serotonin in the brain.
Washington, July 05 (ANI): A new study has suggested that children born to women who take certain antidepressants, including selective serotonin reuptake inhibitors, during the first trimester of pregnancy may modestly increase the risk of developing autism spectrum disorder (ASD).
Based on the result of two 8-week placebo-controlled studies including 861 patients with MDD and a 52-week open-label study including 599 patients, the company believes that the drug is associated with decreased sexual dysfunction, which is something of an Achilles' heel for selective serotonin reuptake inhibitors (SSRIs).
This type of interaction may be overlooked because of the relatively safe drug-drug interaction profile of selective serotonin reuptake inhibitors (SSRIs).
Women on serotonin reuptake inhibitors who took Viagra reported improved sexual function after eight weeks, compared with those who took a placebo.

Full browser ?